Genomic Vision Société Anonyme reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.593 million compared to EUR 0.511 million a year ago. Revenue was EUR 0.826 million compared to EUR 0.743 million a year ago.

Net loss was EUR 6.4 million compared to EUR 2.57 million a year ago.